MIRA INFORM REPORT

 

 

Report Date :

16.02.2011

 

IDENTIFICATION DETAILS

 

Name :

HIGH HOPE INT'L GROUP JIANGSU MEDICINES & HEALTH PRODUCTS

 

 

Registered Office :

12-13/F, High Hope Building, No. 91, Baixia Road, Baixia District, Nanjing, Jiangsu Province, 210001 Pr

 

 

Country :

China

 

 

Financials (as on) :

31.12.2008

 

 

Date of Incorporation :

10.10.1992

 

 

Com. Reg. No.:

320000000004071

 

 

Legal Form :

One-Person Limited Liability Company

 

 

Line of Business :

Selling Biochemical Drug and Medical Machinery

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 200,000

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

                   (01.04.2010)                  

Current Rating

(30.06.2010)

China

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Company name & address 

 

HIGH HOPE INT'L GROUP JIANGSU MEDICINES & HEALTH PRODUCTS

IMP. & EXP. CORP. LTD.

12-13/f, high hope building, no. 91, baixia road,

baixia district, nanjing, jiangsu PROVINCE, 210001 PR CHINA

TEL: 86 (0) 25-84691948/84653291          FAX: 86 (0) 25-84691500

 

EXECUTIVE SUMMARY

 

NCORPORATION DATE : oct. 10, 1992

REGISTRATION NO.                  : 320000000004071

REGISTERED LEGAL FORM     : ONE-PERSON LIMITED LIABILITY COMPANY

CHIEF EXECUTIVE                        : MR. MA CHI (CHAIRMAN)

STAFF STRENGTH                    : 150

REGISTERED CAPITAL : CNY 20,000,000

BUSINESS LINE                        : TRADING

TURNOVER                              : CNY 915,727,000 (AS OF DEC. 31, 2008)

EQUITIES                                 : CNY 28,698,000 (AS OF DEC. 31, 2008)

PAYMENT                                : AVERAGE

RECOMM. CREDIT RANGE       : UP TO USD 200,000 (PERIODICAL REVIEW)

MARKET CONDITION                : COMPETITIVE

FINANCIAL CONDITION             : FAIRly stable

OPERATIONAL TREND  : STEADY

GENERAL REPUTATION           : AVERAGE

EXCHANGE RATE                     : CNY 6.83 = USD 1

 

 

Adopted abbreviations

 

ANS - amount not stated           

NS - not stated 

SC - subject company (the company inquired by you)

NA - not available          

CNY - China Yuan Renminbi

 


 

Rounded Rectangle: HISTORY 

 

 


SC was registered as a State-owned enterprise at Jiangsu Provincial Administration for industry & commerce (AIC - the official body of issuing and renewing business license) on Oct. 10, 1992 and has been under present ownership since 2007.

 

Company Status: One-person Limited Liability Company

Single person LLC refers to a limited liability company set up by only one natural person or legal person as the single shareholder of it.

The minimum registered capital of Single person LLC is CNY100,000. The shareholder’s capital contributes, as set out by the articles of associations should be a lump-sum payment in full.

One natural person can only invest in and set up one limited liability company, which is not permitted to invest in and set up a new Single person LLC.

As to any one-person limited liability company, the sole-investor nature of the natural person or legal person shall be indicated in the registration documents of the company and shall be indicated in the business license thereof as well.

The regulation of Single person LLC should be set up by the shareholder

The regulation of Single person LLC has no shareholder meeting.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SC’s registered business scope includes selling Chinese patent drug, traditional Chinese medicinal materials, chemical agent, chemical raw materials, antibiotic, biochemical drug, class, medical machinery; importing and exporting various kinds of commodities and technology, domestic trading and storage.

 

SC is mainly engaged in selling biochemical drug and medical machinery.

 

Mr. Ma Chi has been legal representative and chairman of SC since 2008.

 

SC is known to have approx. 150 employees at present.

 

SC is currently operating at the above stated address, and this address houses its operating office in the commercial zone of Nanjing. Our checks reveal that SC rents the premise, but the area is unspecified.

 

Rounded Rectangle: WEB SITE 

 


http://www.mehecojs.cn/  The design is professional and the content is well organized. At present it is in both Chinese and English versions.

 

Email: mehecojs@mehecojs.cn

 

 

Rounded Rectangle: KEY EVENTS/RECENT DEVELOPMENT 

 

 


Changes of its registered information:

Date of change

Item

Before the change

After the change

2007-10-12

Company name

Jiangsu Medicine Health Care Article Imp. & Exp. (Group) Co.

present one

Legal form

State-owned enterprise

One-person Limited Liability Company

Registered capital

CNY 8,600,000

CNY 20,000,000

2008-10-8

Legal representative

Wu Yang

Ma Chi

 

Unspecified

Registration No.

3200001100944

320000000004071

 

 

 

Rounded Rectangle: OWNERSHIP/MANAGEMENT BACKGROUND 

 

 


MAIN SHAREHOLDERS:

 
Name                                                                                      % of Shareholding

 

Jiangsu High Hope International Group Co., Ltd.                                       100

Tel: +86 25 84691000/84691010

Fax: +86 25 84572097

E-mail: myy@high-hope.com

Website: http://www.high-hope.com/

 

 

Rounded Rectangle: MANAGEMENT 

 

 


l         Chairman:

Mr. Ma Chi, ID# 320107195211303413, born in 1952 with university education. He is currently responsible for the overall management of SC.

 

Working Experience(s):

 

From 2008 to present                 Working in SC as chairman

 

l         General manager:

Mr. Chen Guofu, ID # 320103195604011938, born in 1956 with university education. He is currently responsible for the daily management of SC.

 

Working Experience(s):

 

At present                     Working in SC as general manager.

 

*Officials:

=======

Name                                                                            Title

Li Bin  ID # 320102196307041633                                    Director  

Xu Shigang  ID # 210204196901025794                            Director

Lu Jie  ID # 320103196310100522                                   Supervisor

 

 

Rounded Rectangle: BUSINESS OPERATIONS
 BACKGROUND
 

 

 


SC is mainly engaged in selling biochemical drug and medical machinery.

 

SC’s products mainly include vitamins, antibiotics, surgical dressings, amino acid, Chinese patent medicine, and so on.

      

 

SC sources its materials 30% from domestic market, and 70% from overseas market. SC sells 80% of its products in domestic market, and 20% to overseas market.

 

The buying terms of SC include Check, T/T, L/C and Credit of 30-60 days. The payment terms of SC include Check, T/T, L/C and Credit of 30-60 days.

 

 

Rounded Rectangle: RELATED COMPANIES

 BACKGROUND
 

 

 


SC is known to have the following subsidiaries: (website sources)

 

Aland (Jiangsu) Nutraceutical Co., Ltd.

Ju Rong Xin Xi Ya Clothing Co., Ltd.

Etc.

 

Rounded Rectangle: PAYMENT

 BACKGROUND
 

 

 


Overall payment appraisal :

(  ) Excellent      (  ) Good      (X) Average      (  ) Fair      (  ) Poor      (  ) Not yet determined

The appraisal serves as a reference to reveal SC's payments habits and ability to pay.  It is based on the 3 weighed factors:  Trade payment experience (through current enquiry with SC's suppliers), our delinquent payment and our debt collection record concerning SC.

 

Trade payment experience : SC did not provide any name of trade/service suppliers and we have no other sources to conduct the enquiry at present.

 

Delinquent payment record :  None in our database.

 

Debt collection record :No overdue amount owed by SC was placed to us for collection within the last 6 years.

 

 


Rounded Rectangle: BANKING

 BACKGROUND

 

 


Bank of China Jiangsu Branch

 

AC# 044138090010000327

 

Relationship: Normal

 

 

Rounded Rectangle: FINANCIAL HIGHLIGHTS

 BACKGROUND
 

 

 


Balance Sheet

Unit: CNY’000

 

as of Dec. 31, 2007

as of Dec. 31, 2008

Cash & bank

10,792

41,148

Inventory

21,402

21,443

Accounts receivable

95,849

64,642

Trading financial assets

1,172

0

Advances to supplies

30,758

45,319

Other receivables

44,080

3,827

Other current assets

0

0

 

------------------

------------------

Current assets

204,053

176,379

Fixed assets net value

1,305

1,454

Projects under construction

0

0

Long-term investments

11,150

11,150

Financial assets available for sale

0

2,814

Intangible and other assets

0

0

 

------------------

------------------

Total assets

216,508

191,797

 

=============

=============

Short loans

44,800

49,220

Accounts payable

49,994

37,822

Other Accounts payable

34,252

13,444

Notes payable

0

9,978

Advances from clients

65,302

53,824

Taxes payable

-1,988

-3,090

Accrued payroll

1,491

1,490

Other current liabilities

0

0

 

-----------------

-----------------

Current liabilities

193,851

162,688

Long term liabilities

0

411

 

------------------

------------------

Total liabilities

193,851

163,099

Shareholders equities

22,657

28,698

 

------------------

------------------

Total liabilities & equities

216,508

191,797

 

=============

=============

 

Income Statement (as of Dec. 31, 2008)

Unit: CNY’000

Turnover

915,727

Cost of goods sold

877,451

     Sales expense

22,467

     Management expense

12,287

     Finance expense

3,059

Investment income

4,048

Non-operating income

361

Other incomes

310

Profit before tax

5,182

Less: profit tax

343

Profits

4,839

Note: SC has not lodged the latest annual returns in the local registry, hence no up-to-date detailed financial information could be provided.

 

Important Ratios

=============

 

as of Dec. 31, 2007

as of Dec. 31, 2008

*Current ratio

1.05

1.08

*Quick ratio

0.94

0.95

*Liabilities to assets

0.90

0.85

*Net profit margin (%)

/

0.53

*Return on total assets (%)

/

2.52

*Inventory /Turnover ×365

/

9 days

*Accounts receivable/Turnover ×365

/

26 days

*Turnover/Total assets

/

4.77

* Cost of goods sold/Turnover

/

0.96

 

 

Rounded Rectangle: FINANCIAL COMMENTS

 BACKGROUND
 

 

 


PROFITABILITY: AVERAGE

l         The turnover of SC appears fairly good in its line.

l         SC’s net profit margin is average.

l         SC’s return on total assets is average.

l         SC’s cost of goods sold is high, comparing with its turnover.

 

LIQUIDITY: AVERAGE

l         The current ratio of SC is maintained in a normal level.

l         SC’s quick ratio is maintained in a normal level.

l         The inventory of SC is maintained in an average level.

l         The accounts receivable of SC appears fairly large.

l         SC’s short-term loan appears LARGE in both 2 years.

l         SC’s turnover is in a fairly good level, comparing with the size of its total assets.

 

LEVERAGE: FAIR

l         The debt ratio of SC is fairly high.

l         The risk for SC to go bankrupt is average.

 

Overall financial condition of the SC: Fairly stable.

 

 

Rounded Rectangle: REMARKS

 BACKGROUND
 

 

 


SC is considered medium-sized in its line with fairly stable financial conditions. The large amount of short loans could be a threat to SC’s financial condition. A credit line up to USD 200,000 appears to be within SC’s capacities upon a periodical review basis.

 

 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.50

UK Pound

1

Rs.73.07

Euro

1

Rs.61.63

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.